4//SEC Filing
Bredt David 4
Accession 0000950170-25-013752
CIK 0002012593other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:30 PM ET
Size
5.3 KB
Accession
0000950170-25-013752
Insider Transaction Report
Form 4
Bredt David
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+100,000→ 100,000 totalExercise: $16.60Exp: 2035-02-03→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2025, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Rapport Therapeutics, Inc.
CIK 0002012593
Entity typeother
Related Parties
1- filerCIK 0002022087
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:30 PM ET
- Size
- 5.3 KB